Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker

doi:10.3748/wjg.v20.i36.12734

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 36

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9527)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

746

WORD

362

HTML

5857

Tables (1-3)

176

Sum=7141

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1102

Download

1284

Sum=2386

Sep 28, 2014 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Sep 28, 2014; 20(36): 12734-12752
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.12734

Table 3 Human immunodeficiency virus prevalence among high risk human immunodeficiency virus parenteral-transmission population groups in the Middle East and North Africa (other than people who inject drugs)

Country	Population	Seroprevalence (%)	Ref.
Bahrain	Children with hereditary hemolytic anemia	1.6	[257]
Egypt	Blood or blood products recipients	4.8	[380]
	Thalassemia patients	0	[381]
	Children with hemophilia	0	[382]
Iran	Thalassemia patients	0	[44,113,160,168,277,284,288-291,383]
	Hemophilia patients	0-2.3	[161,277,281-284,287]
Jordan	Multi-transfused patients	0	[304]
Lebanon	Multi-transfused patients	0	[384]
Morocco	Hemodialysis patients	0	[316]
Pakistan	Multi-transfused patients	0.98	[385]
	Hemodialysis patients	0.98	[277]
Qatar	Children with thalassemia	38.5	[386]
Saudi Arabia	Multi-transfused, thalassemia and sickle cell disease patients	1.3	[387]
	Children undergoing cancer therapy	0	[70]
	Hemodialysis patients	0	[388]
Tunisia	Hemodialysis patients	0	[359]
	Hemophiliacs	8.6	[365]

Results shown are not of an exhaustive and systematic literature review.

Citation: Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker. World J Gastroenterol 2014; 20(36): 12734-12752
URL: https://www.wjgnet.com/1007-9327/full/v20/i36/12734.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i36.12734